L-ELISA MICA for humans quantifies MICA in serum, plasma, cell lysates or the human cell culture medium. The dosage will only recognize natural and recombinant human MICA.
L-ELISA MICA for humans quantifies MICA in serum, plasma, cell lysates or the human cell culture medium. The dosage will only recognize natural and recombinant human MICA.
Method principle
L的ELISA (immuno-enzymatic test) solid phase sandwich for human MICA is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), binding to the target on a different epitope from the capture antibody. A conjugate enzyme was incorporated into the assay. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.
Strict validation
Each batch manufactured from this ELISA kit is tested according to its quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
The Class I major histocompatibility complex (CMH) proteins are widely expressed and mediate the recognition of intracellular antigens by cytotoxic T cells. A related protein family, the MHC Class I (CMI) protein, is recognized by NKG2D, a receptor on NK and T cells, and promotes anti-tumour activity. MICA protein, a member of the MIC family, is widely expressed in many tumours, and it is believed that MICA/NKG2D interaction stimulates T-cell anti-tumour reactivity. MICA and MICB mRNA are widely expressed in normal tissues, with MICA protein present in virtually all tissues with the exception of the nervous system, suggesting that MIC protein expression may be just one component of the immune system's anti-tumour activity.
Sensitivity
Sensitivity of the dosage: 1.09 pg/ml.
Measurement range
Dose range: 1.6-100 pg/ml.
Duration of dosing
Total duration of dosing: 4 hours.
Reproducibility
Coefficient of variation in intra-dose 5.1%, inter-dose 6.6%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15914214 |
| Specifications |
| Accession number | Q29983 |
| Dose range | 1.6-100 pg/ml |
| Sensitivity of the dosage | 1.09 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Cellular lysates, Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 100507436 |
| Gene symbol(s) | MICA |
| Coefficient of inter-dose variation | 6.6% |
| Coefficient of intra-dose variation | 5.1% |
| Contents of kits | 96-well pre-coated plate, Standard (2 vials), Standard dilution stamp, Biotinylated detection anticorps, Streptavidine-HRP, HRP diluent, Wash pad, Chromagen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 μl; plasma, 50 μl; cell lysate, 50 μl; supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h |
Origin and customs
| Manufacturer ref. | BMS2302 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.